Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome: Results of the Multicenter GEIST Registry.
Sergio Raposeiras-Roubin, Francesco Santoro, Luca Arcari...
https://pubmed.ncbi.nlm.nih.gov/39918532Actively Recruiting
Age: 18Years +
All Genders
ID04361994
The GErman Italian Spanish Takotsubo (GEIST) Registry
Led by Prof. Dr. med. Ingo Eitel · Updated on 2025-12-26
500
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
P
Prof. Dr. med. Ingo Eitel
Lead Sponsor
U
University of Foggia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are gathering information from patients with Takotsubo syndrome in an international and multicenter registry called GEIST. This registry aims to better understand the disease by collecting detailed data on patients' demographics, clinical signs, laboratory results, heart imaging and tests, treatments, hospital course, complications, and outcomes over both short and long terms. The study collects data during the patients' hospital stays and continues with follow-up through structured telephone interviews for those not regularly seen at study centers. It includes both past patient data collected retrospectively and new patients enrolled prospectively. This ongoing registry allows for continuous data collection to capture the clinical course and outcomes of Takotsubo syndrome. Participants contribute data that include clinical profiles, heart tests, treatments, and complications. Researchers monitor outcomes such as all-cause mortality at 0 days, 3 months, and 6 months, as well as in-hospital complications. Long-term follow-up helps track patient health beyond hospitalization, with the total study duration extending through December 2035.
CONDITIONS
Brief Title
The GErman Italian Spanish Takotsubo (GEIST) Registry
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Patients with Takotsubo syndrome
- Aged 18 years or older
You will not qualify if you...
- Patients without Takotsubo syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring
Duration - Duration of index hospitalization
Participants who undergo routine care are observed during their index hospitalization for Takotsubo syndrome.
1 to several visits during hospitalization
Long-term Monitoring
Duration - Up to several years
Participants are followed up long-term through structured telephone interviews or outpatient visits to collect outcome data.
Periodic telephone interviews and outpatient visits
Trial Site Locations
Total: 2 locations
1
Universität zu Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538
Actively Recruiting
2
University of Foggia
Foggia, Italy
Actively Recruiting
Loading map...
Research Team
I
Ingo Eitel, Prof. Dr.
T
Thomas Stiermaier, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry.
Francesco Santoro, Thomas Stiermaier, Iván J Núñez Gil...
https://pubmed.ncbi.nlm.nih.gov/39260785Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry.
Ibrahim El-Battrawy, Francesco Santoro, Iván J Núñez-Gil...
https://pubmed.ncbi.nlm.nih.gov/38348805Happy Heart Syndrome: Frequency, Characteristics, and Outcome of Takotsubo Syndrome Triggered by Positive Life Events.
Thomas Stiermaier, Alexandra Walliser, Ibrahim El-Battrawy...
https://pubmed.ncbi.nlm.nih.gov/35772855Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome: Results From the GEIST Registry.
Ibrahim El-Battrawy, Francesco Santoro, Thomas Stiermaier...
https://pubmed.ncbi.nlm.nih.gov/34052189